Harshil Dhruv

Company: Proteovant Therapeutics

Job title: Associate Director - Biology

Seminars:

Discovery & Characterization of an IKZF2 Selective Molecular Glue Degrader with Best In-Class Potential 4:30 pm

Proteovant molecular glues show selective degradation of IKZF2 in vitro and in vivo IKZF2 degradation in vivo translates to efficacy in immune-competent tumor bearing miceRead more

day: Day Two